RDC — Redcare Pharmacy NV Share Price
Last trade - 00:00- €2.64bn
- €2.74bn
- €2.37bn
- 50
- 23
- 76
- 46
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.46 | ||
| Price to Tang. Book | 36.39 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.12 | ||
| EV to EBITDA | 93.72 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -5.17% | ||
| Return on Equity | -9.04% | ||
| Operating Margin | -1.64% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 968.06 | 1,060.32 | 1,204.35 | 1,798.76 | 2,370.57 | 2,993.57 | 3,624.39 | 27.59% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Redcare Pharmacy NV is a company based in the Netherlands that retails pharmaceutical products online. The Company focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The Company is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
Directors
- Jan Pyttel CSU (55)
- Stefan Feltens CEO
- Stephan Weber DCE
- Bjoern Soeder VSU (48)
- Jasper Eenhorst CFO (48)
- Theresa Holler COO
- Marc Fischer CIO
- Jerome Cochet SUB (42)
- Frank Koehler SUB (56)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 1st, 1970
- Public Since
- October 13th, 2016
- No. of Employees
- 2,659
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- XETRA
- Shares in Issue
- 20,578,391
- Address
- Erik de Rodeweg 11/13, SEVENUM, 5975 WD
- Web
- https://www.redcare-pharmacy.com/about-us
- Phone
- Contact
- Monica Ambrosi
- Auditors
- Forvis Mazars LLP
Latest News for RDC
Upcoming Events for RDC
Q1 2025 Redcare Pharmacy NV Earnings Release
Q1 2025 Redcare Pharmacy NV Earnings Call
Redcare Pharmacy NV Annual Shareholders Meeting
Half Year 2025 Redcare Pharmacy NV Earnings Release
Similar to RDC
Cantourage SE
XETRA
Hellofresh SE
XETRA
FAQ
As of Today at 22:53 UTC, shares in Redcare Pharmacy NV are trading at €128.50. This share price information is delayed by 15 minutes.
Shares in Redcare Pharmacy NV last closed at €128.50 and the price had moved by -1.15% over the past 365 days. In terms of relative price strength the Redcare Pharmacy NV share price has underperformed the FTSE Global All Cap Index by -3.63% over the past year.
The overall consensus recommendation for Redcare Pharmacy NV is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreRedcare Pharmacy NV does not currently pay a dividend.
Redcare Pharmacy NV does not currently pay a dividend.
Redcare Pharmacy NV does not currently pay a dividend.
To buy shares in Redcare Pharmacy NV you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €128.50, shares in Redcare Pharmacy NV had a market capitalisation of €2.64bn.
Here are the trading details for Redcare Pharmacy NV:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: RDC
Based on an overall assessment of its quality, value and momentum Redcare Pharmacy NV is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Redcare Pharmacy NV is €168.80. That is 31.36% above the last closing price of €128.50.
Analysts covering Redcare Pharmacy NV currently have a consensus Earnings Per Share (EPS) forecast of -€1.09 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Redcare Pharmacy NV. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -15.57%.
As of the last closing price of €128.50, shares in Redcare Pharmacy NV were trading -2.72% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Redcare Pharmacy NV PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €128.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Redcare Pharmacy NV's management team is headed by:
- Jan Pyttel - CSU
- Stefan Feltens - CEO
- Stephan Weber - DCE
- Bjoern Soeder - VSU
- Jasper Eenhorst - CFO
- Theresa Holler - COO
- Marc Fischer - CIO
- Jerome Cochet - SUB
- Frank Koehler - SUB